The global hesperidin market was valued at US$ 190.1 billion in 2021 and is estimated to expand at a compound annual growth rate (CAGR) of 7.3% from 2021 to 2031. By the end of the forecast period, the market is expected to reach a value of US$ 384.3 million. Hesperidin, a bioflavonoid found in citrus fruits such as lemons, oranges, and tangerines, has seen increasing demand due to its various health benefits and applications in pharmaceuticals, food & beverage, and cosmetics & personal care industries.

Get a concise overview of key insights from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=44691

Regional Analysis

North America is expected to account for a major share of the global hesperidin market during the forecast period. The region's market growth is driven by the increasing prevalence of cardiovascular diseases, advancements in healthcare and pharmaceutical industries, and rising awareness of hesperidin's therapeutic benefits. In the U.S., consumption of hesperidin is projected to be 1,776 metric tons by the end of 2021, with the market predicted to rise at a volume CAGR of 5.7% during the forecast period.

Competitive Landscape

The hesperidin market is characterized by the presence of several key players who are focusing on product innovation, expanding their product portfolios, and increasing their market presence through strategic initiatives. Some of the key players in the market include:

Achemo Corporation
Auraleafs Labs Private Limited
BOCSCI Inc.
BioCrick Co., Ltd.
Benepure Corporation
Bolise Co., Limited
Chengdu Runde Pharmaceutical Co., Ltd.
Morre-Tec Industries, Inc.
Haihang Industry
Di'ao Pharma
NAGASE & CO., LTD.
Plantnat
Zhejiang Kangle Pharmaceutical Co., Ltd.
VIVAN Life Sciences
Tokyo Chemical Industry Co., Ltd.

Contact:

Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453